Home > Income Statement > STRIDES PHARMA SCIENCE

STRIDES PHARMA SCIENCE
Revenue

    Back to Income Statement
STRIDES PHARMA SCIENCE is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

STRIDES PHARMA SCIENCE Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹4,565 Cr₹3,890 Cr₹3,688 Cr₹3,070 Cr₹3,316 Cr

What is the latest Revenue of STRIDES PHARMA SCIENCE ?

The latest Revenue ratio of STRIDES PHARMA SCIENCE is ₹4,565 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹4,565 Cr
Mar2024₹3,890 Cr
Mar2023₹3,688 Cr
Mar2022₹3,070 Cr
Mar2021₹3,316 Cr

How is Revenue of STRIDES PHARMA SCIENCE Trending?

Years Revenue % Change
Mar2025 ₹4,565 Cr
17.36
Mar2024 ₹3,890 Cr
5.47
Mar2023 ₹3,688 Cr
20.13
Mar2022 ₹3,070 Cr
-7.41
Mar2021 ₹3,316 Cr -

Compare Revenue of peers of STRIDES PHARMA SCIENCE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
STRIDES PHARMA SCIENCE ₹7,846.7 Cr -2.6% -3% 32% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹417,028.0 Cr 0.3% 9% 8.6% Stock Analytics
DIVIS LABORATORIES ₹170,237.0 Cr 1.9% 5.9% 12.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹146,801.0 Cr 0.6% 9.5% 45% Stock Analytics
CIPLA ₹108,861.0 Cr 1.6% 1.8% -7.9% Stock Analytics
DR REDDYS LABORATORIES ₹107,435.0 Cr -1.5% 5.7% 14.5% Stock Analytics


STRIDES PHARMA SCIENCE Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
STRIDES PHARMA SCIENCE

-2.6%

-3%

32%

SENSEX

-1.8%

-1.6%

7.3%


You may also like the below Video Courses